Clinical Trial Update: Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating serplulimab in combination with chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Serplulimab (serplulimab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING